Welcome to our dedicated page for Scientific Ind news (Ticker: SCND), a resource for investors and traders seeking the latest updates and insights on Scientific Ind stock.
Introduction
Scientific Industries (SCND) is an established life science tool provider that designs, manufactures, and markets benchtop laboratory equipment, advanced bioprocessing systems, and catalyst research instruments on a global scale. With a focus on digital integration and precision engineering, the company bridges traditional laboratory protocols with modern, digital innovations. Its comprehensive portfolio, which includes instruments such as vortex mixers, digital shakers, and automated bioprocess sensors, is built to meet the rigorous demands of contemporary research environments.
Core Business and Product Lines
The company operates two primary segments: its Benchtop Laboratory Equipment Operations and its Bioprocessing Systems Operations. Under its benchtop product line, Scientific Industries offers a wide array of instruments including:
- Mixers and Shakers: Devices such as vortex mixers (designed to thoroughly mix samples in test tubes and beakers), high-speed touch mixers, orbital shakers, and integrated digital control systems ensure that laboratory protocols are executed with consistent reproducibility.
- Rotators and Rockers: Benchtop multi-purpose rotators and rockers facilitate precise mixing actions and provide flexibility in handling different types of laboratory containers.
- Incubators and Magnetic Stirrers: Refrigerated incubators and incubator shakers, combined with programmable magnetic stirrers, support research processes where temperature control and continuous agitation are crucial.
In parallel, the company has advanced its position in bioprocessing through its innovative DOTS platform. By converting standard shake flasks into smart mini bioreactors, this digitally integrated system utilizes state-of-the-art sensors and actuators designed to continuously monitor parameters such as biomass, dissolved oxygen, and fluorescence. The digital nature of the platform allows real-time process optimization, meeting the dynamic needs of synthetic biology and industrial process development.
Technological Integration and Digital Advances
One of the key differentiators for Scientific Industries is its commitment to integrating digital technologies with laboratory processes. The use of modern bioprocess sensors and automated control systems not only enhances process reliability but also delivers actionable insights. The DOTS Multiparameter Sensor (MPS) is a prime example of this synergy, enabling laboratories to reduce scale-up costs and streamline bioprocess development. Digital sensors and data analytics software provide researchers with the tools to adjust process parameters on-the-fly, ensuring that experimental setups remain robust and reproducible.
Market Position and Industry Impact
Operating at the intersection of research instrumentation and digital bioprocessing, Scientific Industries has carved a significant niche within the life sciences sector. The company’s products are indispensable in environments that demand precision and efficiency, such as university research labs, hospital research centers, and pharmaceutical development facilities. Its comprehensive approach to laboratory instrumentation—ranging from traditional benchtop equipment to automated bioprocessing solutions—addresses a broad spectrum of research needs, providing both immediate operational benefits and long-term methodological improvements.
Operational Strengths and Competitive Landscape
Scientific Industries continues to focus on enhancing operational efficiencies through cost reduction initiatives and strategic product innovations. The company’s emphasis on digital information exchange and real-time data monitoring positions it well against competitors who rely on traditional, manual instrumentation. While the global market for laboratory equipment is highly competitive, SCND distinguishes itself by integrating digitally simplified interfaces and advanced sensor technology with established hardware reliability.
Innovation and Expertise in Bioprocessing
With a strong R&D backbone, the company has continuously evolved its product portfolios to keep pace with innovations in synthetic biology and process engineering. The development of the DOTS platform reflects a deep understanding of the challenges faced during bioprocess scale-up, where data integration and process optimization are paramount. Industry professionals appreciate that Scientific Industries not only supplies high-quality instrumentation but also provides the technological framework required to reduce experimental failures and improve process throughput. This dual emphasis on quality and digital connectivity solidifies the company’s reputation as an authoritative source in laboratory and bioprocessing technology.
Conclusion
In summary, Scientific Industries (SCND) stands out as a comprehensive provider of innovative laboratory and bioprocessing solutions. The company skillfully combines traditional benchtop equipment with next-generation digital sensors and control systems, addressing the complex requirements of modern research and industrial bioprocessing. Its products offer a blend of reliability, precision, and digital sophistication that not only streamline laboratory workflows but also enable significant performance enhancements in experimental and production processes. For stakeholders seeking a thorough and unbiased overview of the company's operations, Scientific Industries offers a transparent look at its evolving product strategies, operational improvements, and advanced technological integrations.
This detailed analysis serves as a valuable resource for understanding the critical role of Scientific Industries in enhancing laboratory efficiency and driving forward innovations in digital bioprocessing. Whether used by academic researchers, industrial scientists, or strategic planners, the company’s offerings continue to provide essential tools and insights that underpin modern advancements in the life sciences.
Scientific Industries (OTCQB: SCND), a life sciences tool provider and developer of digitally simplified bioprocessing products, has announced its fiscal year 2024 financial results conference call scheduled for April 1, 2025, at 11:00 AM Eastern Time. The company filed its Form 10K and issued a press release on March 31, 2025, for the fiscal year ended December 31, 2024.
Investors can participate by dialing (844) 481-2706 (domestic) or (412) 317-0662 (international). A webcast will be available on the Company's Investor Relations page, with replay access through April 8, 2025. The company's subsidiary, Scientific Bioprocessing (SBI), specializes in bioprocess sensors, actuators, and data analytics software, offering solutions including the DOTS Platform that transforms standard shake flasks into smart mini bioreactors.
Scientific Industries (SCND) reported financial results for fiscal year 2024, showing mixed performance across divisions. The company's Bioprocessing Systems Operations achieved 24% revenue growth to $1.7M, driven by the newly launched DOTS MPS system. However, overall net revenues decreased 3.6% to $10.7M, with Benchtop Laboratory Equipment sales declining 7% to $9.0M.
The company significantly reduced operating expenses by 21% to $11.4M and cut total net losses by 29% to $6.4M ($0.61 per share). Gross profit was $4.7M with a 44.2% margin. The company maintained a strong financial position with $2.6M in cash and equivalents and $6.5M in working capital.
Key developments include the expansion of DOTS MPS into mammalian cell culture markets, launch of the VIVID WORKSTATION automated pill counter, and planned AI model integration. The company is currently conducting trials with six major pharma companies and plans to launch new products in 2025, including an optical pH sensor and liquid injection system.
Scientific Industries (SCND) reported Q3 2024 financial results with net revenues of $2.8M, up 7.1% YoY. The company's Bioprocessing Systems Operations showed three consecutive quarters of growth, with Q3 revenues up 6.6% to $452.5K. Gross margins improved 350 basis points to 49.2%. Operating expenses decreased by 23% to $2.6M, while net loss reduced by 46% to $1.18M. The company's DOTS MPS system was validated for mammalian cell culture use, and a new VIVID WORKSTATION targeting pharmacy chains is set to launch. Working capital stood at $8.0M as of September 30, 2024.
Scientific Industries (OTCQB: SCND) announced it will file Form 10Q on November 14, 2024, for its third quarter financial results ended September 30, 2024. The company will release Q3 2024 results before market open on November 15, 2024, followed by a conference call at 11:00 AM ET. The call will be accessible via phone at (844) 481-2706 or (412) 317-0662 (international) and through webcast on the company's Investor Relations page. A replay will be available until November 22, 2024.
Scientific Industries (OTCQB:SCND), a life sciences tool provider and developer of simplified bioprocessing products, will participate in the Craig-Hallum Bioprocessing Conference on September 19, 2024. John Nicols, Chairman of Scientific Bioprocessing (SBI), and John Moore, Chairman of the Company, will be featured in a fireside chat at 12:30 p.m. ET.
The conference will be held virtually, and a replay of the fireside chat will be available on the Company's investor website after the event. This presentation offers an opportunity for investors to gain insights into Scientific Industries' latest developments and strategies in the bioprocessing sector.
Scientific Industries (OTCQB:SCND) reported financial results for Q2 2024, ending June 30. Key highlights include:
- Net revenues: $2.6M (Q2) and $5.1M (H1), down 11.2% and 12.8% YoY respectively
- Gross profit margin: 48.8% (Q2), up 350 basis points YoY
- Operating expenses decreased by 26.5% (Q2) and 22% (H1) YoY
- Net loss reduced to $1.28M (Q2) and $3.34M (H1), improvements of 44% and 28% YoY
- Cash and investments totaled $3.9M with $8.6M working capital
The company saw strong pipeline growth for Bioprocessing DOTS MPS and Torbal VIVID products, with cost-saving initiatives significantly improving financial results.
Scientific Industries (OTCQB:SCND), a life sciences tool provider and developer of digitally simplified bioprocessing products, has announced plans to file its Form 10Q on August 14, 2024, for the second quarter ended June 30, 2024. The company will issue a press release reporting its Q2 2024 results before the market opens on August 15, 2024.
A conference call for investors will be held on August 15, 2024, at 11:00 AM Eastern Time. Interested parties can dial (844) 481-2706 or (412) 317-0662 (international) to participate. A live webcast will also be available on the company's Investor Relations page. A replay of the call will be accessible through August 23, 2024.
Scientific Industries (OTCQB:SCND) will participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024. The life sciences tool provider will host a webcasted presentation at 2:45 PM ET and engage in one-on-one virtual meetings with investors. The webcast can be accessed on the conference homepage or directly through the provided link. This event allows the company to present its digitally simplified bioprocessing products and engage directly with potential investors.
Scientific Industries (OTCQB:SCND) reported financial results for Q1 of fiscal year 2024, ending March 31, 2024.
Net revenues decreased by 11.5% to $2.5 million from $2.8 million in the prior year period. Bioprocessing Systems Operations revenues increased by 42% to $316,100, while Benchtop Laboratory Equipment revenues decreased by 15% to $2.2 million.
Gross profit decreased by 24% to $1.0 million, with a gross margin of 42%, down from 48% in the prior year period. Operating expenses decreased by 17.7%, resulting in a reduced loss from operations of $2.05 million compared to $2.37 million in the previous year.
The company shipped its first Multi-Parameter Sensor (MPS) under the DOTS platform in April 2024 and completed an equity financing in Q1 2024. Cash, cash equivalents, and investments totaled $4.8 million as of March 31, 2024.
Scientific Industries, Inc. (OTCQB:SCND) will host an investor call on May 16, 2024, to discuss its first quarter financial results. The company plans to file Form 10Q on May 15, 2024, and issue a press release on May 16, 2024, reporting its Q1 2024 results. Interested parties can participate in the call by dialing (844) 481-2706 or (412) 317-0662 (international) or via live webcast. A replay will be available until May 23, 2024.
FAQ
What is the current stock price of Scientific Ind (SCND)?
What is the market cap of Scientific Ind (SCND)?
What is the primary focus of Scientific Industries (SCND)?
Which industries are served by Scientific Industries?
What are the main product lines offered by SCND?
How does Scientific Industries incorporate digital technology into its products?
What is the DOTS platform and why is it significant?
How does SCND differentiate itself in the competitive laboratory equipment market?
Who typically uses the products manufactured by Scientific Industries?
What benefits do SCND's bioprocessing systems offer?
